Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2509
Source ID: NCT03622762
Associated Drug: Green Tea Extract
Title: Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Diabetic Nephropathy Type 2
Interventions: DRUG: green tea extract|DRUG: Placebo
Outcome Measures: Primary: Soluble RAGE concentration, Before and after the intervention using the serum extracted from the patient using sandwich ELISA., 90 days | Secondary: Glomerular filtration rate, Before and after the intervention, it will be evaluated by means of a determination of serum creatinine, which will be analyzed with the spectrophotometry method and from its result the glomerular filtration rate is calculated., 90 days|Albumin/creatinine ratio, Before and after intervention by spectrophotometry, 90 days|Fasting plasma glucose, Before and after intervention spectrophotometry, 90 days|Glycated Hemoglobin concentration, It will be analyzed by liquid chromatography, 90 days|Systolic and diastolic arterial pressure, Before and after intervention using a digital baumanometer, 90 days|Alanine aminotransferase, Before and after intervention by spectrophotometry, 90 days|Aspartate aminotransferase, Before and after intervention by spectrophotometry, 90 days | Other: Total cholesterol, Before and after intervention by spectrophotometry, 90 days|triglycerides, Before and after intervention by spectrophotometry, 90 days|High-density lipoprotein cholesterol, Before and after intervention by spectrophotometry, 90 days|Low-density lipoprotein cholesterol, Before and after intervention by friedewall formula, 90 days|Weight and visceral fat %, Before and after intervention using a vascula of impedance, 90 days
Sponsor/Collaborators: Sponsor: Centro Universitario de Ciencias de la Salud, Mexico
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2018-07-15
Completion Date: 2019-06-20
Results First Posted:
Last Update Posted: 2019-02-20
Locations: Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, 44340, Mexico
URL: https://clinicaltrials.gov/show/NCT03622762